WA People
BILL · 2017–18 SESSION · LATEST VERSION ESHB 2356

HB 2356: Stem cell therapies

Concerning stem cell therapies not approved by the United States food and drug administration.

Summary

  • Requires licensed health care professionals to notify patients when the stem cell therapy they provide has not been approved by the Food and Drug Administration (FDA).

From the Engrossed Substitute Senate Bill Report (ESHB 2356), written by the Legislature's nonpartisan staff. Read the full report ↗

Enacted Enacted · Chapter 216, Laws of 2018
  1. IntroducedJan 8, 2018
  2. Out of committeeJan 22, 2018
  3. Passed HouseFeb 12, 2018
  4. Passed SenateMar 2, 2018
  5. GovernorMar 22, 2018
  6. LawMar 22, 2018
Prime sponsor
Eileen Cody (D-34)
Introduced
January 8, 2018 in the House
Last action
March 22, 2018
Session law
Chapter 216, Laws of 2018
Budget
Has a fiscal note
Versions
HB 2356, ESHB 2356

AN ACT Relating to stem cell therapies not approved by the United States food and drug administration;

Sponsors

Prime sponsor: Eileen Cody (D-34)

5 co-sponsors (4 Democrats, 1 Republican)

Norm Johnson R-14Joan McBride D-48Laurie Jinkins D-27Cindy Ryu D-32Timm Ormsby D-3

Votes

House · Final Passage

Passed February 12, 2018
Version voted on: ESHB 2356
97 Yea 0 Nay 0 Absent 1 Excused
PartyYeaNayAbsentExcused
Democrat49001
Republican48000
How each member voted

Yea (97)

Excused (1)

Permalink to this vote

Senate · 3rd Reading & Final Passage

Passed March 2, 2018
Version voted on: ESHB 2356
48 Yea 0 Nay 0 Absent 1 Excused
PartyYeaNayAbsentExcused
Democrat25001
Republican23000
How each member voted

Excused (1)

Permalink to this vote

History

  1. Effective date 6/7/2018. (ESHB 2356)
  2. Chapter 216, 2018 Laws. (ESHB 2356)
  3. Governor signed. (ESHB 2356)
  4. Delivered to Governor. (ESHB 2356)
  5. President signed. (ESHB 2356)
  6. Speaker signed. (ESHB 2356)
  7. Third reading, passed; yeas, 48; nays, 0; absent, 0; excused, 1. (ESHB 2356)
  8. Rules suspended. Placed on Third Reading. (ESHB 2356)
  9. Placed on second reading by Rules Committee. (ESHB 2356)
  10. Passed to Rules Committee for second reading. (ESHB 2356)
  11. HLTC - Majority; do pass. (ESHB 2356)
  12. First reading, referred to Health & Long Term Care. (ESHB 2356)
  13. Third reading, passed; yeas, 97; nays, 0; absent, 0; excused, 1. (ESHB 2356)
  14. Rules suspended. Placed on Third Reading. (ESHB 2356)
  15. Floor amendment(s) adopted. (ESHB 2356)
  16. Returned to second reading for amendment. (ESHB 2356)
  17. Rules suspended. Placed on Third Reading. (ESHB 2356)
  18. 1st substitute bill substituted. (ESHB 2356)
  19. 1st substitute bill substituted.
  20. Rules Committee relieved of further consideration. Placed on second reading. (ESHB 2356)
  21. Rules Committee relieved of further consideration. Placed on second reading.
  22. Referred to Rules 2 Review. (ESHB 2356)
  23. Referred to Rules 2 Review.
  24. HCW - Majority; 1st substitute bill be substituted, do pass. (ESHB 2356)
  25. HCW - Majority; 1st substitute bill be substituted, do pass.
  26. First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).
  27. Prefiled for introduction.

HB 2356 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page